Amylyx Pharmaceuticals Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FMR LLC | 02/17/2026 | 16.52 M | $199.54 M | 45.16% | 17.70% |
| BLACKROCK, INC. | 02/12/2026 | 9.05 M | $109.38 M | 26.80% | 9.70% |
| PERCEPTIVE ADVISORS LLC | 02/17/2026 | 8.28 M | $100.08 M | -7.46% | 8.88% |
| TCG CROSSOVER MANAGEMENT, LLC | 02/17/2026 | 6.24 M | $75.43 M | 0.00% | 6.69% |
| VANGUARD GROUP INC | 01/29/2026 | 5.80 M | $70.12 M | 10.07% | 6.22% |
| COMMODORE CAPITAL LP | 02/17/2026 | 5.65 M | $68.25 M | 38.63% | 6.05% |
| SATURN V CAPITAL MANAGEMENT LLC | 02/17/2026 | 4.50 M | $54.32 M | -2.35% | 4.82% |
| JANUS HENDERSON GROUP PLC | 02/17/2026 | 4.47 M | $53.99 M | 76.08% | 4.78% |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 02/17/2026 | 3.36 M | $40.53 M | -0.01% | 3.60% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 02/17/2026 | 3.11 M | $37.56 M | 28.45% | 3.33% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/17/2026 | 2.78 M | $33.55 M | -59.26% | 2.98% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 2.61 M | $31.57 M | 29.97% | 2.80% |
| MORGAN STANLEY | 02/13/2026 | 2.36 M | $28.51 M | 21.00% | 2.53% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 2.17 M | $26.16 M | 19.51% | 2.32% |
| ALMITAS CAPITAL LLC | 02/17/2026 | 2.12 M | $25.64 M | 0.00% | 2.27% |
| STATE STREET CORP | 02/13/2026 | 2.07 M | $25.00 M | 27.67% | 2.22% |
| GREAT POINT PARTNERS LLC | 02/17/2026 | 1.75 M | $21.14 M | 2.94% | 1.88% |
| 683 CAPITAL MANAGEMENT, LLC | 02/17/2026 | 1.65 M | $19.93 M | -6.25% | 1.77% |
| EVENTIDE ASSET MANAGEMENT, LLC | 02/13/2026 | 1.51 M | $18.28 M | 0.04% | 1.62% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 1.34 M | $16.14 M | 211.05% | 1.43% |
| DEUTSCHE BANK AG\ | 02/11/2026 | 1.33 M | $16.11 M | -2.36% | 1.43% |
| FRANKLIN RESOURCES INC | 02/11/2026 | 1.20 M | $14.50 M | 100.00% | 1.29% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 02/10/2026 | 1.00 M | $12.13 M | -9.30% | 1.08% |
| LOGOS GLOBAL MANAGEMENT LP | 02/17/2026 | 950.00 K | $11.48 M | -34.48% | 1.02% |
| NORTHERN TRUST CORP | 02/17/2026 | 937.76 K | $11.33 M | 14.05% | 1.00% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 02/18/2026 | 890.36 K | $10.76 M | 2.79% | 0.95% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/17/2026 | 858.68 K | $10.37 M | -41.84% | 0.92% |
| WOODLINE PARTNERS LP | 02/17/2026 | 845.41 K | $10.21 M | 0.01% | 0.91% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 02/13/2026 | 835.68 K | $10.10 M | -10.69% | 0.90% |
| BOXER CAPITAL MANAGEMENT, LLC | 02/17/2026 | 800.00 K | $9.66 M | -11.11% | 0.86% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 771.25 K | $9.32 M | 51.29% | 0.83% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 712.99 K | $8.61 M | 10.51% | 0.76% |
| STEMPOINT CAPITAL LP | 02/17/2026 | 565.14 K | $6.83 M | 104.11% | 0.61% |
| UBS GROUP AG | 01/29/2026 | 543.32 K | $6.56 M | -61.31% | 0.58% |
| SOFINNOVA INVESTMENTS, INC. | 02/13/2026 | 527.10 K | $6.37 M | 100.00% | 0.56% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 02/12/2026 | 506.24 K | $6.12 M | -27.68% | 0.54% |
| AMERIPRISE FINANCIAL INC | 02/17/2026 | 502.37 K | $6.07 M | 276.28% | 0.54% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 02/17/2026 | 499.76 K | $6.04 M | 0.00% | 0.54% |
| FEDERATED HERMES, INC. | 02/12/2026 | 457.41 K | $5.53 M | 115.38% | 0.49% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/17/2026 | 412.87 K | $4.99 M | 147.07% | 0.44% |
| CORMORANT ASSET MANAGEMENT, LP | 02/17/2026 | 400.00 K | $4.83 M | -20.00% | 0.43% |
| PARKMAN HEALTHCARE PARTNERS LLC | 02/17/2026 | 381.76 K | $4.61 M | -34.09% | 0.41% |
| PATIENT SQUARE CAPITAL LP | 02/12/2026 | 350.00 K | $4.23 M | 10.65% | 0.38% |
| CITADEL ADVISORS LLC | 02/17/2026 | 344.97 K | $4.17 M | 47.00% | 0.37% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 344.40 K | $4.16 M | 249.94% | 0.37% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/17/2026 | 335.00 K | $4.05 M | -87.99% | 0.36% |
| ACUTA CAPITAL PARTNERS, LLC | 02/17/2026 | 333.26 K | $4.03 M | 0.00% | 0.36% |
| TWO SIGMA ADVISERS, LP | 02/17/2026 | 328.40 K | $3.97 M | 129.65% | 0.35% |
| ALPHA WAVE GLOBAL, LP | 02/13/2026 | 317.68 K | $3.84 M | -2.94% | 0.34% |
| BARCLAYS PLC | 02/13/2026 | 295.18 K | $3.57 M | -28.72% | 0.32% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Amylyx Pharmaceuticals Inc institutional Ownership - FAQ's
During the previous two years, 240 institutional investors and hedge funds held shares of Amylyx Pharmaceuticals Inc. The most heavily invested institutionals were:
DEUTSCHE BANK AG\: 1.27 M
DIMENSIONAL FUND ADVISORS LP: 903,192
Connor, Clark & Lunn Investment Management Ltd.: 868,325
JUPITER ASSET MANAGEMENT LTD: 592,654
VANGUARD FIDUCIARY TRUST CO: 586,152
FEDERATED HERMES, INC.: 363,546
120.34% of Amylyx Pharmaceuticals Inc stock is owned by institutional investors.
Institutional investors have bought a total of 117.40 M shares in the last 24 months. This purchase volume represents approximately $1.68 B in transactions.